PEPGEN INC. Variable Lease, Cost
PEPGEN INC. (PEPG) reported Variable Lease, Cost of $1.45 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-04
- PEPGEN INC. variable lease, cost for the quarter ending 2023-12-31 was $284.00K.
- PEPGEN INC. variable lease, cost for the quarter ending 2023-09-30 was $272.00K.
- PEPGEN INC. variable lease, cost for the quarter ending 2023-06-30 was $277.00K.
- PEPGEN INC. variable lease, cost for the quarter ending 2023-03-31 was $64.00K.
- PEPGEN INC. variable lease, cost for fiscal 2025 was $1.45M, a 26.11% decline from fiscal 2024.
- PEPGEN INC. variable lease, cost for fiscal 2024 was $1.97M, a 97.89% increase from fiscal 2023.
- PEPGEN INC. variable lease, cost for fiscal 2023 was $993.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.45M 10-K · filed 2026-03-04 | |||
| 2024-12-31 | $1.97M 10-K · filed 2026-03-04 | |||
| 2023-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $556.00K derived: sum of 2 quarters · filed 2025-02-24 | $833.00K derived: sum of 3 quarters · filed 2025-02-24 | $993.00K 10-K · filed 2025-02-24 |
| 2023-09-30 | $272.00K 10-Q · filed 2023-11-08 | $549.00K derived: sum of 2 quarters · filed 2023-11-08 | $709.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $277.00K 10-Q · filed 2023-08-08 | $437.00K 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | $64.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |